Universities Partner to Combat Antibiotic ResistancE

Professor Mark Shirtliff, PhD, is shown in his lab in the Department of Microbial Pathogenesis at the University of Maryland School of Dentistry. Credit: University of Maryland School of Dentistry

Baltimore, Md.—The University of Maryland, Baltimore (UMB) has granted worldwide, exclusive licensing rights for a new vaccine technology to Serenta Biotechnology, a Gaithersburg, Maryland-based startup. The license is based on technology co-owned by UMB and Northern Arizona University, and is the basis for a multivalent vaccine for infections caused by Staphylococcus aureus, a bacterial strain often resistant to antibiotics, according to a UMB news release.

“This is a very promising vaccine candidate with the potential to prevent a range of S. aureus infections, including those that are resistant to antibiotics available for treating methicillin-resistant S. aureus (MRSA), and has the potential to save many lives,” observes Patrik Bavoil, PhD, chair of University of Maryland School of Dentistry’s Department of Microbial Pathogenesis.

According to UMB, the licensed technology is a multivalent vaccine consisting of four specific antigens expressed when the organism exists within a biofilm, and one antigen expressed when S. aureus is in its free-floating form. In a mouse model of bone implant infection, the vaccine prevented MRSA infection. Using an antigen discovery platform in collaboration with UMB, Serenta Biotechnology plans to develop a pipeline of vaccines targeting additional pathogens, such as Streptococcus pyogenes, Klebsiella pneumoniae and Acinetobacter baumannii.

Add a Comment

Your email address will not be published. Required fields are marked *

Palmero Announces X-Ray Apron Recycle/Trade-in Program

Palmero Healthcare, a Hu-Friedy subsidiary, is pleased to announce our latest...

ClearCorrect Acquired by Global Dental Leader Straumann Group

ROUND ROCK, Texas, Aug. 17, 2017 (GLOBE NEWSWIRE) — ClearCorrect LLC,...

ADA and MD Anderson team up for Oral Cancer Symposium

A closer look at how dentists, oncologists, head and neck surgeons...

ACFF Now Accepting Applications for 2017 Grant Program

For the second consecutive year, The Canada-United States Chapter of the...

LANAP and LAPIP Protocols: Laser Gum Disease Protocols

Over 50% of US adults have gum disease.  Offer your patients...

IRIS HD USB 3.0 Intraoral Camera

Experience the Clarity in High Definition The new IRIS HD USB...

A New Adhesive/Primer Ideal for Indirect Restorations

At BISCO, adhesion is our passion. BISCO prides itself on developing...

KDZ Bruxer® Aesthetic

Bring the strength of full-contour zirconia into the facial zone with...